These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

871 related items for PubMed ID: 25204288

  • 1. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
    Gandhi NS, Tekade RK, Chougule MB.
    J Control Release; 2014 Nov 28; 194():238-56. PubMed ID: 25204288
    [Abstract] [Full Text] [Related]

  • 2. Combinatorial therapeutic approaches with RNAi and anticancer drugs using nanodrug delivery systems.
    Babu A, Munshi A, Ramesh R.
    Drug Dev Ind Pharm; 2017 Sep 28; 43(9):1391-1401. PubMed ID: 28523942
    [Abstract] [Full Text] [Related]

  • 3. Simultaneous nanocarrier-mediated delivery of siRNAs and chemotherapeutic agents in cancer therapy and diagnosis: Recent advances.
    Bidar N, Darroudi M, Ebrahimzadeh A, Safdari M, de la Guardia M, Baradaran B, Goodarzi V, Oroojalian F, Mokhtarzadeh A.
    Eur J Pharmacol; 2022 Jan 15; 915():174639. PubMed ID: 34919890
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy.
    Xiao B, Ma L, Merlin D.
    Expert Opin Drug Deliv; 2017 Jan 15; 14(1):65-73. PubMed ID: 27337289
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nanotechnology lights up the antitumor potency by combining chemotherapy with siRNA.
    Sun J, Ogunnaike EA, Jiang X, Chen Z.
    J Mater Chem B; 2021 Sep 22; 9(36):7302-7317. PubMed ID: 34382987
    [Abstract] [Full Text] [Related]

  • 11. Nanoparticle-mediated delivery of small RNA molecules in tumor therapy.
    Aigner A, Fischer D.
    Pharmazie; 2016 Jan 22; 71(1):27-34. PubMed ID: 26867350
    [Abstract] [Full Text] [Related]

  • 12. Nano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistant cancers.
    Tsouris V, Joo MK, Kim SH, Kwon IC, Won YY.
    Biotechnol Adv; 2014 Jan 22; 32(5):1037-50. PubMed ID: 24924617
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nanocarrier-based co-delivery of small molecules and siRNA/miRNA for treatment of cancer.
    Chitkara D, Singh S, Mittal A.
    Ther Deliv; 2016 Jan 22; 7(4):245-55. PubMed ID: 27010986
    [Abstract] [Full Text] [Related]

  • 17. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J, Farzan M.
    World J Gastroenterol; 2015 Nov 14; 21(42):12022-41. PubMed ID: 26576089
    [Abstract] [Full Text] [Related]

  • 18. Non-viral vectors combined delivery of siRNA and anti-cancer drugs to reverse tumor multidrug resistance.
    Xue R, Pan Y, Xia L, Li J.
    Biomed Pharmacother; 2024 Sep 14; 178():117119. PubMed ID: 39142247
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficient nanocarriers of siRNA therapeutics for cancer treatment.
    Subhan MA, Torchilin VP.
    Transl Res; 2019 Dec 14; 214():62-91. PubMed ID: 31369717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.